Skip to main content

and
  1. No Access

    Article

    IL1RAP expression as a measure of leukemic stem cell burden at diagnosis of chronic myeloid leukemia predicts therapy outcome

    N Landberg, N Hansen, M Askmyr, H Ågerstam, C Lassen, M Rissler in Leukemia (2016)

  2. Article

    Open Access

    Modeling chronic myeloid leukemia in immunodeficient mice reveals expansion of aberrant mast cells and accumulation of pre-B cells

    Chronic myeloid leukemia (CML) is a myeloproliferative neoplasm that, if not treated, will progress into blast crisis (BC) of either myeloid or B lymphoid phenotype. The BCR-ABL1 fusion gene, encoding a constitut...

    M Askmyr, H Ågerstam, H Lilljebjörn, N Hansen, C Karlsson in Blood Cancer Journal (2014)

  3. Article

    Open Access

    SOCS2 is dispensable for BCR/ABL1-induced chronic myeloid leukemia-like disease and for normal hematopoietic stem cell function

    Suppressor of cytokine signaling 2 (SOCS2) is known as a feedback inhibitor of cytokine signaling and is highly expressed in primary bone marrow (BM) cells from patients with chronic myeloid leukemia (CML). Ho...

    N Hansen, H Ågerstam, M Wahlestedt, N Landberg, M Askmyr, M Ehinger, M Rissler in Leukemia (2013)